EUVIMEDEUVIMED entdecken
Crossref

Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway

Kai Yang, Xian Gao, Chuanxi Sun, Luyang Zhao, Yuanyuan Zhang, Yujie Zhang, Yuhao Yang, Shuangshuang Guo iD, Miaomiao Chen, Hanhan Li, Zhenyu Ji iD, Dandan Fan

Molecular Carcinogenesis · 2026-12 · 65 (12) · 1582-1595

DOI: 10.1002/mc.70179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 19.09.2026. Verfasst von Kai Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Glycolysis, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 43 Literaturangaben. Gefördert von: the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a highly aggressive malignancy with strong metastatic potential. Protein 4.1 R, encoded by EPB41 , is a membrane cytoskeleton protein that plays an essential role in maintaining plasma membrane stability and cytoskeletal organization. Recent studies have indicated that the protein 4.1 R played a tumor‐suppressive role in multiple cancer types. However, the relationship between protein 4.1 R and glycolysis in melanoma remains unclear. In this study, we aimed to explore the relationship between protein 4.1 R expression and glucose metabolism and its mechanism of action in melanoma. Our results indicated that protein 4.1 R silencing significantly promoted the proliferation, migration and invasion of melanoma cells in vitro and accelerated tumor growth in vivo and increased glucose consumption, extracellular acidification rate, and lactate and ATP production, accompanied by reduced oxidative phosphorylation (OXPHOS). Protein 4.1 R silencing was associated with increased phosphorylation of PI3K, AKT and mTOR signaling components. Treatment with the PI3K inhibitor LY294002 partially reversed the effects of protein 4.1 R knockdown on melanoma cells. In conclusion, these findings suggest that protein 4.1 R may negatively regulate melanoma progression through mechanisms associated with glycolytic remodeling and PI3K/AKT/mTOR signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesGlycolysisProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMelanomaMembrane ProteinsCytoskeletal ProteinsHumansAnimalsSignal TransductionCell ProliferationMiceCell Line, TumorCell MovementDisease ProgressionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

PI3K/AKT/mTORglycolysismelanomaproliferationprotein 4.1 R

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMembrane ProteinsCytoskeletal ProteinsMTOR protein, human

Autor:innen und Institutionen

  • Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
  • Institute of Children's Health, Henan Academy of Medical Sciences, Zhengzhou, China.
  • The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
  • Department of Pathology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.

ORCID-Profile: Shuangshuang Guo, Zhenyu Ji

Förderung

  • the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences

Zitieren

APA

Yang, K., Gao, X., Sun, C., Zhao, L., Zhang, Y., Zhang, Y., Yang, Y., Guo, S., Chen, M., Li, H., Ji, Z., & Fan, D. (2026). Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway. Molecular Carcinogenesis, 65(12), 1582-1595. https://doi.org/10.1002/mc.70179

Vancouver

Yang K, Gao X, Sun C, Zhao L, Zhang Y, Zhang Y, et al. Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway. Molecular Carcinogenesis. 2026;65(12):1582-1595. doi:10.1002/mc.70179

BibTeX
@article{Yang2026,
  author = {Yang, Kai and Gao, Xian and Sun, Chuanxi and Zhao, Luyang and Zhang, Yuanyuan and Zhang, Yujie and Yang, Yuhao and Guo, Shuangshuang and Chen, Miaomiao and Li, Hanhan and Ji, Zhenyu and Fan, Dandan},
  title = {Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {12},
  pages = {1582--1595},
  doi = {10.1002/mc.70179}
}
Kostenlos starten →